In particular, a meta-analysis of 19 clinical trials compared the effectiveness and safety of TNF blocking agents (Infliximab, Adalimumab, and Certolizumab) in the treatment of CD, showing that anti-TNF therapy is safe and significantly more effective than placebo (8). Here, TNF is linked to Cowden disease.